Dr. Reddy’s Laboratories Ltd

Today we announced our Q2 FY'27 financial results. For more details click here: #FY27FinancialResults #DrReddys #WeAreDrReddys #GoodHealthCantWait

Madrid, here we come! @ESMO2026 We are joining the global oncology community at ESMO 2026, Madrid, and look forward to contributing to the exchange of ideas and innovations shaping the future of cancer care. #ESMO26 #DrReddys #Oncology #DrReddysOncology

Progress in oncology is powered by collaboration. Our team is heading to #ESMO26 Meet us at ESMO 2026 or reach out to schedule a conversation with us. #ESMO26 #DrReddys #Oncology #DrReddysOncology

A tiny mesh tube and decades of research. This World Heart Day, swipe through to see the innovation that helped change heart care.    #WorldHeartDay #HeartHealth #ScienceForHealth #CardiovascularHealth #MedicalInnovation #PatientCare

We have entered into an exclusive agreement with Takeda to promote and distribute QDENGA®, India’s first CDSCO-approved dengue vaccine, anticipated to be available in the first half of 2027. Read more: #DrReddys #DenguePrevention

This #InternationalLiteracyDay, our School Improvement Programme, a CSR initiative implemented through Dr. Reddy's Foundation is helping children thrive across 100 govt. schools in Telangana, AP & Himachal Pradesh. #InternationalLiteracyDay #DrReddys #CSR #DRF #EducationMatters

The U.S. FDA approval of our Rituximab biosimilar marks another important milestone for our growing biosimilars portfolio. Read the press release to learn more #DrReddys #WeAreDrReddys #Rituximab #Biosimilars #Biologics #GoodHealthCantWait

Immuno-oncology is opening new possibilities in cancer care. At Abhinandan, G.V. Prasad, leaders and our teams engaged with investigators and advisors on scientific rigor, collaboration, and patient access. #DrReddys #WeareDrReddys #CancerCare #GoodHealthCantWait

With the first-to-market launch of Sugammadex Injection, a generic equivalent of Bridion®, in the U.S., we continue expanding our hospital portfolio, reinforcing our commitment to improving patient access to affordable, high-quality medicines. #DrReddys #GoodHealthCantWait

Today we announced our Q1 FY'27 financial results. Read the full press release for more details : #FY27FinancialResults #DrReddys #WeAreDrReddys #GoodHealthCantWait

RT @AFSAcollab: 🎉 Exciting news! @drreddys has joined the @AFSAcollab! We're proud to partner with Dr. Reddy's Laboratories to help advance animal-free science & accelerate the adoption of human-relevant, non-animal methods in drug development & testing. Welcome to the #AFSAFamily, @drreddys!

As an organization, the cornerstone of our work is closely aligned with our founder’s values, creating access and enabling livelihoods. Our CSR team takes this forward, through initiatives in various areas. #DrReddys #CSR #SpiritOfGiving #GoodHealthCantWait

Our Integrated Annual Report FY 2025–26 is now out. To read it, please find the link in the first comment. #DrReddys #IntegratedAnnualReportFY26 #GoodHealthCantWait #WeAreDrReddys

Click the link to read the complete Integrated Annual Report FY 2025-26:

Launching our 3rd whitepaper, ‘Translational Research Ecosystem: Learnings from the World & Building for India,' from our joint roundtable with Dr. Reddy’s Institute of Life Sciences (DRILS), moderated by Citeline. #GoodHealthCantWait #WeAreDrReddys #TranslationalResearch

Read the full whitepaper for a deep dive to read about the key findings and insights :

We have partnered with Ramdevrao Hospital to establish a Cath Lab in Kukatpally, Hyderabad, expanding local access to advanced cardiac imaging and care , helping address delays in treatment and easing the burden of travel for care. #DrReddys #CSR #HealthcareAccess #CardiacCare

Watch our Co‑Chairman and Managing Director GV Prasad, in conversation with @nikhilkamathcio and Mankind founder Rajeev Juneja #DrReddys #WeAreDrReddys #GoodHealthCantWait #Leadership #Pharma #PurposeDriven #IndustryVoices #Healthcare

With the first-to-market launch of Bosutinib tablets, 400 mg in the U.S., in collaboration with MSN Laboratories Pvt. Ltd., we are strengthening our oncology portfolio while improving patient access to affordable, high-quality medicines. #WeAreDrReddys #GoodHealthCantWait

MV Narasimham, our Chief Financial Officer, has been recognised as the Best CFO in Pharmaceuticals (Individual) at the 9th Annual Business World Best CFO & Finance Strategy Excellence Awards. #DrReddys #WeAreDrReddys #GoodHealthCantWork #BestCFO #BWBestCFO2026 #FinanceExcellence